Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven R Feldman

Showing results (161-170 of 1,291) with videos related to

Pageof 130
Sort By:
Journal of the American Academy of Dermatology|May 17, 2011
A consideration when interpreting outpatient dataTushar S Dabade, Steven R Feldman
Dermatology Online Journal|September 8, 2020
The ethical implications of utilizing advertising techniques to increase biologic treatment willingness in patients with psoriasisJeremy K Bray, Steven R Feldman
Dermatology Online Journal|April 5, 2021
Assessing the utility of the decoy effect on biologic treatment preferenceJeremy K Bray, Steven R Feldman
JAAD International|August 19, 2021
Demographics and the perception of psoriasis therapy adverse effects and treatment preference: A cross-sectional survey of a convenience sample of people with psoriasisJeremy K Bray, Steven R Feldman
The Journal of Dermatological Treatment|July 19, 2011
The compliance pyramidIris H Y Kim, Steven R Feldman
The Journal of Dermatological Treatment|March 14, 2012
Measuring patient satisfaction changes patient satisfactionCandace Glenn, Amy McMichael, Steven R Feldman
Dermatology Online Journal|September 10, 2013
Tachyphylaxis to topical glucocorticoids; what is the evidence?Arash Taheri, Jacob Cantrell, Steven R Feldman
Expert Opinion on Investigational Drugs|October 9, 2018
Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizonAnisha Guda, Steven R Feldman, Lindsay Strowd
The Annals of Pharmacotherapy|June 22, 2022
Review of Calcipotriene and Betamethasone Dipropionate Cream in the Treatment of PsoriasisAlexandra Taylor, Rohan Singh, Steven R Feldman
Journal of Drugs in Dermatology : JDD|March 5, 2020
Management of Residual Psoriasis in Patients on Biologic TreatmentWasim Haidari, Adrian Pona, Steven R. Feldman
Pageof 130

Showing results (161-170 of 1,291) with videos related to

Sort By:
Pageof 130
Journal of the American Academy of Dermatology|May 17, 2011
A consideration when interpreting outpatient dataTushar S Dabade, Steven R Feldman
Dermatology Online Journal|September 8, 2020
The ethical implications of utilizing advertising techniques to increase biologic treatment willingness in patients with psoriasisJeremy K Bray, Steven R Feldman
Dermatology Online Journal|April 5, 2021
Assessing the utility of the decoy effect on biologic treatment preferenceJeremy K Bray, Steven R Feldman
JAAD International|August 19, 2021
Demographics and the perception of psoriasis therapy adverse effects and treatment preference: A cross-sectional survey of a convenience sample of people with psoriasisJeremy K Bray, Steven R Feldman
The Journal of Dermatological Treatment|July 19, 2011
The compliance pyramidIris H Y Kim, Steven R Feldman
The Journal of Dermatological Treatment|March 14, 2012
Measuring patient satisfaction changes patient satisfactionCandace Glenn, Amy McMichael, Steven R Feldman
Dermatology Online Journal|September 10, 2013
Tachyphylaxis to topical glucocorticoids; what is the evidence?Arash Taheri, Jacob Cantrell, Steven R Feldman
Expert Opinion on Investigational Drugs|October 9, 2018
Investigational drugs in phase II clinical trials for moderate to severe plaque psoriasis - potential new treatments on the horizonAnisha Guda, Steven R Feldman, Lindsay Strowd
The Annals of Pharmacotherapy|June 22, 2022
Review of Calcipotriene and Betamethasone Dipropionate Cream in the Treatment of PsoriasisAlexandra Taylor, Rohan Singh, Steven R Feldman
Journal of Drugs in Dermatology : JDD|March 5, 2020
Management of Residual Psoriasis in Patients on Biologic TreatmentWasim Haidari, Adrian Pona, Steven R. Feldman
Pageof 130